# Risk-adapted Therapeutic Strategy in +1q NDMM

> **NCT07045168** · — · NOT_YET_RECRUITING · sponsor: **FengYan Jin** · enrollment: 200 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **OTHER:** risk-scoring model

## Key facts

- **NCT ID:** NCT07045168
- **Lead sponsor:** FengYan Jin
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-15
- **Primary completion:** 2027-09-15
- **Final completion:** 2029-07-04
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07045168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07045168, "Risk-adapted Therapeutic Strategy in +1q NDMM". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07045168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*